Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov 17:e12658.
doi: 10.1002/advs.202512658. Online ahead of print.

Pulmonary-Targeted Nanoparticles Interrupt the Malignant Mechanical and Biochemical Signaling Crosstalk for Idiopathic Pulmonary Fibrosis Therapy

Xue-Na Li  1   2 , Ya-Ping Lin  3 , Xi-Xi Ma  3 , Yue-Fei Fang  3 , Hui Wang  4 , Chun-Hui Cui  3 , Chen Zhang  3 , Jin-You Piao  2 , Jee-Heon Jeong  5 , Xian Wu Cheng  1 , Lei Xing  3 , Hu-Lin Jiang  1   2   3   6   5
Affiliations

Pulmonary-Targeted Nanoparticles Interrupt the Malignant Mechanical and Biochemical Signaling Crosstalk for Idiopathic Pulmonary Fibrosis Therapy

Xue-Na Li et al. Adv Sci (Weinh). .

Abstract

Idiopathic pulmonary fibrosis (IPF) involves transforming growth factor-beta, a key factor that drives biochemical signaling pathways, inducing cellular transdifferentiation and excessive extracellular matrix (ECM) deposition. Increased ECM stiffness alters the mechanical microenvironment of the lung, exacerbating pulmonary dysfunction through mechanical signaling transduction. Here, persistent malignant mechanical and biochemical signaling crosstalk in IPF is demonstrated that drives the relentless progression of the disease. Therefore, inhalable lung-targeted lipid nanoparticles (VB-RT NPs) are developed for co-delivering verteporfin and berbamine to effectively treat IPF by interrupting pulmonary mechanical-biochemical signaling malignant crosstalk. Specifically, VB-RT NPs are modified with tannic acid to scavenge reactive oxygen species and enhance lung targeting, and with L-arginine to penetrate dense ECM and reach deeper lung regions. After being inhaled in a bleomycin model, VB-RT NPs inhibited fibroblast activation and promoted the transition of endothelial cell (EC)-like myofibroblasts to ECs, reducing endothelial-to-mesenchymal transition and fibrotic progression. Additionally, VB-RT NPs blocked the nuclear translocation of the mechanotransducers Yes-associated protein, interrupting fibrosis-related mechanotransduction pathways. The results demonstrate that VB-RT NPs effectively reversed dysregulated mechanical-biochemical signaling crosstalk in fibrotic lungs and halted fibrosis progression, offering a promising therapeutic approach for IPF.

Keywords: extracellular matrix; idiopathic pulmonary fibrosis; malignant crosstalk; mechanical and biochemical signals; mechanotransduction; transforming growth factor‐beta.

PubMed Disclaimer

References

    1. F. J. Martinez, H. R. Collard, A. Pardo, G. Raghu, L. Richeldi, M. Selman, J. J. Swigris, H. Taniguchi, A. U. Wells, Nat. Rev. Dis. Primers 2017, 3, 17074.
    1. T. E. King, Jr., A. Pardo, M. Selman, Lancet 2011, 378, 1949.
    1. R. Suzman, J. Beard, NIH Publ. 2011, 1, 273.
    1. L. Richeldi, H. R. Collard, M. G. Jones, Lancet 2017, 389, 1941.
    1. T. Sun, Z. Huang, W.‐C. Liang, J. Yin, W. Y. Lin, J. Wu, J.‐M. Vernes, J. Lutman, P. Caplazi, S. Jeet, T. Wong, M. Wong, D. J. DePianto, K. B. Morshead, K.‐H. Sun, Z. Modrusan, J. A. Vander Heiden, A. R. Abbas, H. Zhang, M. Xu, E.‐N. N'Diaye, M. Roose‐Girma, P. J. Wolters, R. Yadav, S. Sukumaran, N. Ghilardi, R. Corpuz, C. Emson, Y. G. Meng, T. R. Ramalingam, et al., Sci. Transl. Med. 2021, 13, abe0407.